Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scanfil Q3’25: Adequately priced

Scanfil

The overall picture of Scanfil's Q3 report was fairly neutral. The outlook is positive in both the short and longer term, but the stock has adequately priced in the expected earnings growth. Head of Research Antti Viljakainen summarizes.

Read the latest company report here

Stay up to date
Analyst Interviews

Recent videos

Scanfil Q4’25: Horizontal operational progress
2026-03-09 10:26 Scanfil
Aiforia, Webcast, H2, 2025
2026-03-06 09:00 Aiforia Technologies
VD Intervju: Lär känna W5 Solutions på djupet
2026-03-06 08:11 W5 Solutions
Solwers Q4'25: Fokus på lönsamhet och organisk tillväxt
2026-03-05 13:42
Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
2026-03-05 13:00 Nightingale Health
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.